Registry to Collect Data on Patients Undergoing Segmental Mandibular Defect Reconstruction Following Oral Squamous Cell Carcinoma Resection and Drugs-induced Osteonecrosis

Part of paid clinical trials in Jacksonville, Florida.

Sponsor
AO Innovation Translation Center
Study ID
NCT04098146
Status
Recruiting

Conditions

  • Mandibular Reconstruction
  • Segmental Mandibular Defects

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Surgical Resection and Reconstruction — PROCEDURE
    One stage reconstruction: Osseous reconstruction is performed in the same surgery of the tumor/mandibular resection. It is also known as immediate or primary reconstruction. Second stage reconstruction: Osseous reconstruction is performed after the tumor/mandibular resection surgery as an independent surgery. After the mandibular resection a temporary alloplastic bridging might be put in place. It is also known as delayed or secondary reconstruction.

Study Details

Prospective will be collected in a minimum of 300 patients presenting with an acquired segmental mandibular defect ≥ 2 cm secondary to OSSC removal and drugs-induced osteonecrosis, and who require mandibular reconstruction.

Key Dates

Start date
Sep 12, 2022
Status verified
Aug 2025
Primary completion
Jun 30, 2030
Completion
Dec 31, 2030

Study Design

Enrollment
300 participants (estimated)

Arms

  • Arm: Mandibular Reconstruction
    Patients undergoing segmental mandibular defect reconstruction. The decision of one stage or two stage reconstruction is done according to the patient and treating surgeon preferences following the local standard of care

Primary Outcome Measure

Demographics [ Time Frame: Baseline until resection surgery approximately 4 weeks ]

Central Contacts

Locations (5)

FacilityCityStateZIPSite coordinators
University of Florida College of MedicineJacksonvilleFlorida32209
Rui Fernandes, Prof
+1 904 244 3901
University of Illinois ChicagoChicagoIllinois60612
Nicolas Callahan, MD
Northwell Health Cancer InstituteNew Hyde ParkNew York11042
Brett Miles
6462846215
Brett Miles (PRINCIPAL_INVESTIGATOR)
Danielle Scarola (SUB_INVESTIGATOR)
Mount Sinai HospitalNew YorkNew York10029
Mohammed Khan, MD
John Peter Smith Health NetworkFort WorthTexas76104
Roderick Kim, MD
+1 817-702-6979

Find similar trials in Jacksonville, FL